BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36346574)

  • 1. Mucosal Leishmaniasis of the lip: Report of an Exuberant case in a Young man.
    de Arruda JAA; Tomo S; Cunha JLS; Guevara JR; Martínez I; Reyes O; Bracho V; Sanchez C; de Andrade BAB; Villarroel-Dorrego M
    Head Neck Pathol; 2023 Jun; 17(2):540-545. PubMed ID: 36346574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to
    Figueiredo LP; Almeida LDC; Magalhães A; Arruda S; Lessa MM; Carvalho EM
    Am J Trop Med Hyg; 2020 Oct; 103(4):1493-1495. PubMed ID: 32748768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis.
    Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD
    J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461
    [No Abstract]   [Full Text] [Related]  

  • 4. Lip leishmaniasis: a case series with molecular identification and literature review.
    Mohammadpour I; Motazedian MH; Handjani F; Hatam GR
    BMC Infect Dis; 2017 Jan; 17(1):96. PubMed ID: 28122496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal leishmaniasis of the lip: an emerging clinical form in Tunisia.
    Hammami-Ghorbel H; Ben Abda I; Badri T; Chelbi H; Fenniche S; Mokhtar I; Bouratbine A; Benmously-Mlika R; Aoun K
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1212-5. PubMed ID: 24910266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis.
    Goyonlo VM; Vahabi-Amlashi S; Taghavi F
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
    Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
    Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    Motta AC; Arruda D; Souza CS; Foss NT
    Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases.
    Muvdi-Arenas S; Ovalle-Bracho C
    Biomedica; 2019 Aug; 39(Supl. 2):58-65. PubMed ID: 31529834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis.
    Crone CG; Helleberg M
    J Travel Med; 2020 Feb; 27(1):. PubMed ID: 31776570
    [No Abstract]   [Full Text] [Related]  

  • 11. [Open therapeutic study with aminosidine sulfate in mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis].
    Romero GA; Lessa HA; Macêdo VO; Carvalho EM; Barral A; Magalhães AV; Orge MG; Abreu MV; Marsden PD
    Rev Soc Bras Med Trop; 1996; 29(6):557-65. PubMed ID: 9011880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia].
    El Fékih N; Sliti N; Kharfi M; Trabelsi S; Khaled S; Fazaa B; Kamoun MR
    Med Trop (Mars); 2008 Dec; 68(6):634-6. PubMed ID: 19639835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
    Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L
    Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report.
    Ferreira Terceiro BR; Torraca TSS; Braga FPB; Martins ACDC; Brahim LR; Saheki MN; Miranda LFC; Schubach AO; Valete-Rosalino CM
    Rev Soc Bras Med Trop; 2019 Jan; 52():e20180236. PubMed ID: 30652793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal leishmaniasis mimicking squamous cell carcinoma in a liver transplant recipient.
    Ramos A; Múñez E; García-Domínguez J; Martinez-Ruiz R; Chicharro C; Baños I; Suarez-Massa D; Cuervas-Mons V
    Transpl Infect Dis; 2015 Jun; 17(3):488-92. PubMed ID: 25816835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient.
    Botelho MCB; Ferreira LL; Fikaris S; Prado-Ribeiro AC; Soubhia AMP; Biasoli ER; Miyahara GI; Bernabé DG
    Head Neck Pathol; 2021 Sep; 15(3):1069-1073. PubMed ID: 33372239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.
    Solomon M; Sahar N; Pavlotzky F; Barzilai A; Jaffe CL; Nasereddin A; Schwartz E
    Emerg Infect Dis; 2019 Apr; 25(4):642-648. PubMed ID: 30882319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated American muco-cutaneous leishmaniasis caused by Leishmania braziliensis braziliensis in a patient with AIDS: a case report.
    Machado ES; Braga Mda P; Da Cruz AM; Coutinho SG; Vieira AR; Rutowitsch MS; Cuzzi-Maya T; Grimaldi júnior G; Menezes JA
    Mem Inst Oswaldo Cruz; 1992; 87(4):487-92. PubMed ID: 1343662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful combined therapy with Glucantime™ and pentoxifylline for the nasal mucosal lesion recently developed in a leishmaniasis patient having untreated cutaneous lesion for seven decades.
    Brustolin AÁ; Ramos-Milaré ÁCFH; de Castro KR; Mota CA; Pelloso SM; Silveira TGV
    Parasitol Int; 2021 Dec; 85():102422. PubMed ID: 34280531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.